Versant Venture Management, LLC Repare Therapeutics Inc. Transaction History
Versant Venture Management, LLC
- $45 Million
- Q2 2024
A detailed history of Versant Venture Management, LLC transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Versant Venture Management, LLC holds 2,646,657 shares of RPTX stock, worth $9.55 Million. This represents 19.39% of its overall portfolio holdings.
Number of Shares
2,646,657
Previous 2,646,657
-0.0%
Holding current value
$9.55 Million
Previous $12.5 Million
29.94%
% of portfolio
19.39%
Previous 17.38%
Shares
1 transactions
Others Institutions Holding RPTX
# of Institutions
69Shares Held
36.6MCall Options Held
51.7KPut Options Held
17.7K-
Bvf Inc San Francisco, CA10.3MShares$37.3 Million1.04% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$12.2 Million4.62% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$12 Million0.26% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$10.7 Million17.66% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.51MShares$9.06 Million0.08% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $151M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...